{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:39:16Z","timestamp":1788471556894,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MSCA-ITN-ETN - European Training Networks","award":["An Integrated Platform for Developing Brain Cancer Diagnostic Techniques (AiPBAND) project ID 764282"],"award-info":[{"award-number":["An Integrated Platform for Developing Brain Cancer Diagnostic Techniques (AiPBAND) project ID 764282"]}]},{"DOI":"10.13039\/501100021170","name":"Brain Tumour Research","doi-asserted-by":"publisher","award":["Hanemann"],"award-info":[{"award-number":["Hanemann"]}],"id":[{"id":"10.13039\/501100021170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11060-022-04126-0","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T16:22:04Z","timestamp":1662654124000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["miR-497 and 219 in blood aid meningioma classification"],"prefix":"10.1007","volume":"160","author":[{"given":"Ahmed","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Negroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeja","family":"Urbanic-Purkart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaellla","family":"Vergura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens Oliver","family":"Hanemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"4126_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3389\/fonc.2020.01523","volume":"10","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zhao W, Hou Y, Wen C, Wang J, Wu P, Guo Z (2020) An overview of managements in meningiomas. Front Oncol 10:1523. https:\/\/doi.org\/10.3389\/fonc.2020.01523","journal-title":"Front Oncol"},{"key":"4126_CR2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro-oncology 23:1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro-oncology"},{"key":"4126_CR3","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/s1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383\u2013e391. https:\/\/doi.org\/10.1016\/s1470-2045(16)30321-7","journal-title":"Lancet Oncol"},{"key":"4126_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-019-03104-3","volume":"142","author":"AI Islim","year":"2019","unstructured":"Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD (2019) Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 142:211\u2013221. https:\/\/doi.org\/10.1007\/s11060-019-03104-3","journal-title":"J Neurooncol"},{"key":"4126_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/neuonc\/noz061","volume":"21","author":"F Nassiri","year":"2019","unstructured":"Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-oncology 21:901\u2013910. https:\/\/doi.org\/10.1093\/neuonc\/noz061","journal-title":"Neuro-oncology"},{"key":"4126_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"4126_CR7","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/j.lpm.2018.05.016","volume":"47","author":"P Euskirchen","year":"2018","unstructured":"Euskirchen P, Peyre M (2018) Management of meningioma. La Presse M\u00e9dicale 47:e245\u2013e252. https:\/\/doi.org\/10.1016\/j.lpm.2018.05.016","journal-title":"La Presse M\u00e9dicale"},{"key":"4126_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fgene.2019.00626","volume":"10","author":"M Cui","year":"2019","unstructured":"Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R, Zhang X (2019) Circulating microRNAs in cancer: potential and challenge. Front Genet 10:626","journal-title":"Front Genet"},{"key":"4126_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ (2006) Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer 6:259\u2013269. https:\/\/doi.org\/10.1038\/nrc1840","journal-title":"Nat Rev Cancer"},{"key":"4126_CR10","doi-asserted-by":"publisher","DOI":"10.4161\/2162402X.2014.982407","volume":"5","author":"X Chen","year":"2016","unstructured":"Chen X, Liang H, Zen K, Zhang C-Y (2016) Secreted microRNAs from tumor cells can suppress immune function. Oncoimmunology 5:e982407","journal-title":"Oncoimmunology"},{"key":"4126_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","volume":"22","author":"X Chen","year":"2012","unstructured":"Chen X, Liang H, Zhang J, Zen K, Zhang C-Y (2012) Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22:125\u2013132","journal-title":"Trends Cell Biol"},{"key":"4126_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nbt1392","volume":"26","author":"N Rosenfeld","year":"2008","unstructured":"Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26:462","journal-title":"Nat Biotechnol"},{"key":"4126_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3389\/fphar.2019.01500","volume":"10","author":"NNSB Nik Mohamed Kamal","year":"2020","unstructured":"Nik Mohamed Kamal NNSB, Shahidan WNS (2020) Non-exosomal and exosomal circulatory microRNAs: which are more valid as biomarkers? Front Pharmacol 10:1500","journal-title":"Front Pharmacol"},{"key":"4126_CR14","doi-asserted-by":"publisher","first-page":"55900","DOI":"10.18632\/oncotarget.10152","volume":"7","author":"G Yang","year":"2016","unstructured":"Yang G, Xiong G, Cao Z, Zheng S, You L, Zhang T, Zhao Y (2016) miR-497 expression, function and clinical application in cancer. Oncotarget 7:55900\u201355911. https:\/\/doi.org\/10.18632\/oncotarget.10152","journal-title":"Oncotarget"},{"key":"4126_CR15","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1261\/rna.1034808","volume":"14","author":"LX Yan","year":"2008","unstructured":"Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348\u20132360. https:\/\/doi.org\/10.1261\/rna.1034808","journal-title":"RNA"},{"key":"4126_CR16","doi-asserted-by":"publisher","first-page":"2491291","DOI":"10.1155\/2019\/2491291","volume":"2019","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wu S, Wang L, Kang S, Zhao B, He F, Liu X, Zeng Y, Liu J (2019) Prognostic value of microRNA-497 in various cancers: a systematic review and meta-analysis. Dis mark 2019:2491291\u20132491291. https:\/\/doi.org\/10.1155\/2019\/2491291","journal-title":"Dis mark"},{"key":"4126_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1530\/ERC-11-0082","volume":"18","author":"DM \u00d6zata","year":"2011","unstructured":"\u00d6zata DM, Caramuta S, Vel\u00e1zquez-Fern\u00e1ndez D, Ak\u00e7akaya P, Xie H, H\u00f6\u00f6g A, Zedenius J, B\u00e4ckdahl M, Larsson C, Lui W-O (2011) The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 18:643\u2013655. https:\/\/doi.org\/10.1530\/ERC-11-0082","journal-title":"Endocr Relat Cancer"},{"key":"4126_CR18","doi-asserted-by":"publisher","first-page":"e92847","DOI":"10.1371\/journal.pone.0092847","volume":"9","author":"J-W Xu","year":"2014","unstructured":"Xu J-W, Wang T-X, You L, Zheng L-F, Shu H, Zhang T-P, Zhao Y-P (2014) Insulin-like growth factor 1 receptor (IGF-1R) as a target of miR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS ONE 9:e92847. https:\/\/doi.org\/10.1371\/journal.pone.0092847","journal-title":"PLoS ONE"},{"key":"4126_CR19","doi-asserted-by":"publisher","first-page":"e84311","DOI":"10.1371\/journal.pone.0084311","volume":"9","author":"T Itesako","year":"2014","unstructured":"Itesako T, Seki N, Yoshino H, Chiyomaru T, Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M et al (2014) The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195\/497 cluster. PLoS ONE 9:e84311. https:\/\/doi.org\/10.1371\/journal.pone.0084311","journal-title":"PLoS ONE"},{"issue":"2015","key":"4126_CR20","doi-asserted-by":"publisher","first-page":"35893","DOI":"10.18632\/oncotarget.5651","volume":"6","author":"S Wang","year":"2015","unstructured":"Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M (2015) The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 6(2015):35893\u201335907. https:\/\/doi.org\/10.18632\/oncotarget.5651","journal-title":"Oncotarget"},{"key":"4126_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3892\/etm.2011.428","volume":"3","author":"L Shen","year":"2012","unstructured":"Shen L, Li J, Xu L, Ma J, Li H, Xiao X, Zhao J, Fang L (2012) miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med 3:475\u2013480. https:\/\/doi.org\/10.3892\/etm.2011.428","journal-title":"Exp Ther Med"},{"key":"4126_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2014.05.011","volume":"449","author":"W Li","year":"2014","unstructured":"Li W, Jin X, Deng X, Zhang G, Zhang B, Ma L (2014) The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochem Biophys Res Commun 449:235\u2013240. https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.011","journal-title":"Biochem Biophys Res Commun"},{"key":"4126_CR23","doi-asserted-by":"publisher","first-page":"29527","DOI":"10.18632\/oncotarget.5012","volume":"6","author":"J-J Yan","year":"2015","unstructured":"Yan J-J, Zhang Y-N, Liao J-Z, Ke K-P, Chang Y, Li P-Y, Wang M, Lin J-S, He X-X (2015) miR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget 6:29527\u201329542. https:\/\/doi.org\/10.18632\/oncotarget.5012","journal-title":"Oncotarget"},{"key":"4126_CR24","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3892\/or.2014.3439","volume":"32","author":"W Wang","year":"2014","unstructured":"Wang W, Ren F, Wu Q, Jiang D, Li H, Shi H (2014) MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the Pi3k\/Akt and MAPK\/ERK pathways in ovarian cancer. Oncol Rep 32:2127\u20132133. https:\/\/doi.org\/10.3892\/or.2014.3439","journal-title":"Oncol Rep"},{"key":"4126_CR25","first-page":"7729","volume":"8","author":"C Wei","year":"2015","unstructured":"Wei C, Luo Q, Sun X, Li D, Song H, Li X, Song J, Hua K, Fang L (2015) MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. Int J Clin Exp Pathol 8:7729\u20137739","journal-title":"Int J Clin Exp Pathol"},{"key":"4126_CR26","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.7314\/apjcp.2013.14.6.3499","volume":"14","author":"L Wang","year":"2013","unstructured":"Wang L, Li B, Li L, Wang T (2013) MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells. Asian Pac J Cancer Prev 14:3499\u20133502. https:\/\/doi.org\/10.7314\/apjcp.2013.14.6.3499","journal-title":"Asian Pac J Cancer Prev"},{"key":"4126_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/neuonc\/nos074","volume":"14","author":"NM Teplyuk","year":"2012","unstructured":"Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S (2012) MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro-oncology 14:689\u2013700","journal-title":"Neuro-oncology"},{"key":"4126_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.arcmed.2017.07.002","volume":"48","author":"JE L\u00f3pez-Aguilar","year":"2017","unstructured":"L\u00f3pez-Aguilar JE, Vel\u00e1zquez-Flores MA, Sim\u00f3n-Mart\u00ednez LA, \u00c1vila-Miranda R, Rodr\u00edguez-Florido MA, Garrido RR-E (2017) Circulating microRNAs as biomarkers for pediatric astrocytomas. Arch Med Res 48:323\u2013332","journal-title":"Arch Med Res"},{"key":"4126_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2015.1.JNS141577","volume":"124","author":"X Yue","year":"2016","unstructured":"Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J (2016) Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. J Neurosurg 124:122\u2013128","journal-title":"J Neurosurg"},{"key":"4126_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-016-0393-0","volume":"35","author":"G Regazzo","year":"2016","unstructured":"Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G et al (2016) A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp Clin Cancer Res 35:124. https:\/\/doi.org\/10.1186\/s13046-016-0393-0","journal-title":"J Exp Clin Cancer Res"},{"key":"4126_CR31","doi-asserted-by":"publisher","first-page":"102941","DOI":"10.1016\/j.ebiom.2020.102941","volume":"59","author":"C Negroni","year":"2020","unstructured":"Negroni C, Hilton DA, Ercolano E, Adams CL, Kurian KM, Baiz D, Hanemann CO (2020) GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma. EBioMedicine 59:102941. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102941","journal-title":"EBioMedicine"},{"key":"4126_CR32","doi-asserted-by":"publisher","first-page":"32067","DOI":"10.1038\/srep32067","volume":"6","author":"F Zhi","year":"2016","unstructured":"Zhi F, Shao N, Li B, Xue L, Deng D, Xu Y, Lan Q, Peng Y, Yang Y (2016) A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep 6:32067. https:\/\/doi.org\/10.1038\/srep32067","journal-title":"Sci Rep"},{"key":"4126_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/253957","volume":"2013","author":"J Schageman","year":"2013","unstructured":"Schageman J, Zeringer E, Li M, Barta T, Lea K, Gu J, Magdaleno S, Setterquist R, Vlassov AV (2013) The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int 2013:253957. https:\/\/doi.org\/10.1155\/2013\/253957","journal-title":"Biomed Res Int"},{"key":"4126_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041273","author":"CL Adams","year":"2020","unstructured":"Adams CL, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, Kurian KM, Hilton DA, Hanemann CO (2020) A rapid robust method for subgrouping non-NF2 meningiomas according to genotype and detection of lower levels of M2 macrophages in AKT1 E17K mutated tumours. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21041273","journal-title":"Int J Mol Sci"},{"key":"4126_CR35","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1002\/jcb.28174","volume":"120","author":"S Madadi","year":"2019","unstructured":"Madadi S, Soleimani M (2019) Comparison of miR-16 and cel-miR-39 as reference controls for serum miRNA normalization in colorectal cancer. J Cell Biochem 120:4802\u20134803. https:\/\/doi.org\/10.1002\/jcb.28174","journal-title":"J Cell Biochem"},{"key":"4126_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1515\/revneuro-2020-0023","volume":"31","author":"L Wang","year":"2020","unstructured":"Wang L, Chen S, Liu Y, Zhang H, Ren N, Ma R, He Z (2020) The biological and diagnostic roles of microRNAs in meningiomas. Rev Neurosci 31:771\u2013778. https:\/\/doi.org\/10.1515\/revneuro-2020-0023","journal-title":"Rev Neurosci"},{"key":"4126_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/731479","volume":"2015","author":"P Tiberio","year":"2015","unstructured":"Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V (2015) Challenges in using circulating miRNAs as cancer biomarkers. BioMed Res Int 2015:731479. https:\/\/doi.org\/10.1155\/2015\/731479","journal-title":"BioMed Res Int"},{"issue":"1","key":"4126_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2199-11-74","volume":"11","author":"SA Bustin","year":"2010","unstructured":"Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, Penning LC, Toegel S (2010) Miqe pr\u00e9cis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. Bmc Mol Biol 11(1):74","journal-title":"Bmc Mol Biol"},{"key":"4126_CR39","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1038\/emm.2013.81","volume":"45","author":"F Benz","year":"2013","unstructured":"Benz F, Roderburg C, Vargas Cardenas D, Vucur M, Gautheron J, Koch A, Zimmermann H, Janssen J, Nieuwenhuijsen L, Luedde M et al (2013) U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med 45:e42. https:\/\/doi.org\/10.1038\/emm.2013.81","journal-title":"Exp Mol Med"},{"key":"4126_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cllc.2014.12.006","volume":"16","author":"P Wang","year":"2015","unstructured":"Wang P, Yang D, Zhang H, Wei X, Ma T, Cheng Z, Hong Q, Hu J, Zhuo H, Song Y et al (2015) Early detection of lung cancer in serum by a panel of microRNA biomarkers. Clin Lung Cancer 16:313-319.e1. https:\/\/doi.org\/10.1016\/j.cllc.2014.12.006","journal-title":"Clin Lung Cancer"},{"key":"4126_CR41","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","volume":"61","author":"H Schwarzenbach","year":"2015","unstructured":"Schwarzenbach H, da Silva AM, Calin G, Pantel K (2015) Data normalization strategies for microRNA quantification. Clin Chem 61:1333\u20131342. https:\/\/doi.org\/10.1373\/clinchem.2015.239459","journal-title":"Clin Chem"},{"key":"4126_CR42","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1002\/wrna.1413","volume":"8","author":"KM Kim","year":"2017","unstructured":"Kim KM, Abdelmohsen K, Mustapic M, Kapogiannis D, Gorospe M (2017) RNA in extracellular vesicles. WIREs RNA 8:e1413. https:\/\/doi.org\/10.1002\/wrna.1413","journal-title":"WIREs RNA"},{"key":"4126_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clineuro.2018.05.001","volume":"170","author":"F Mashayekhi","year":"2018","unstructured":"Mashayekhi F, Saberi A, Mashayekhi S (2018) Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma. Clin Neurol Neurosurg 170:84\u201387. https:\/\/doi.org\/10.1016\/j.clineuro.2018.05.001","journal-title":"Clin Neurol Neurosurg"},{"key":"4126_CR44","doi-asserted-by":"publisher","first-page":"751","DOI":"10.31557\/apjcp.2019.20.3.751","volume":"20","author":"H Fouladseresht","year":"2019","unstructured":"Fouladseresht H, Ziaee SM, Erfani N, Doroudchi M (2019) Serum levels of APRIL increase in patients with glioma, meningioma and schwannoma. Asian Pac J Cancer Prev 20:751\u2013756. https:\/\/doi.org\/10.31557\/apjcp.2019.20.3.751","journal-title":"Asian Pac J Cancer Prev"},{"key":"4126_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020560","author":"AA Sofela","year":"2021","unstructured":"Sofela AA, Hilton DA, Ammoun S, Baiz D, Adams CL, Ercolano E, Jenkinson MD, Kurian KM, Teo M, Whitfield PC et al (2021) Fibulin-2: a novel biomarker for differentiating grade II from grade I meningiomas. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020560","journal-title":"Int J Mol Sci"},{"key":"4126_CR46","doi-asserted-by":"publisher","first-page":"e19158","DOI":"10.7759\/cureus.19158","volume":"13","author":"V Carneiro","year":"2021","unstructured":"Carneiro V, Cirino M, Panepucci R, Peria F, Tirapelli D, Colli B, Carlotti CG Jr (2021) The role of microRNA 181d as a possible biomarker associated with tumor progression in meningiomas. Cureus 13:e19158. https:\/\/doi.org\/10.7759\/cureus.19158","journal-title":"Cureus"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-04126-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T09:07:20Z","timestamp":1667207240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-04126-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4126"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-04126-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of UNIVERSITY OF PLYMOUTH (protocol code 17\/18-837and 14\/15-450) and date of approval 27\/ January 2021 for studies involving humans.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study. A copy of the written consent is available for review by the editor-in-chief of this journal on request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}